David Romness, MD
Orthopaedic Surgery · Arlington, VANPI 1487671574
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,839 of the $4,308 with a category attached, or 65.9%. Zimmer Biomet accounts for 62.2% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2022 at $2,272 and has fallen 82.2% since, to $405 in 2025.
Across 56 payments — averaging $76.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$3K
- Johnson & Johnson$573
- Stryker$293
- Davol Inc.$164
- Heron Therapeutics, Inc.$163
- Smith+Nephew$146
- plus $291 from 11 others
Across 6 payments — averaging $10,277 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Fidia Pharma USA Inc.$62K
What the payments were for
- Travel & lodging$1,46934%
- Food & beverage$2,83966%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 19 | $2,678 |
| Johnson & Johnson | 8 | $573 |
| Stryker | 5 | $293 |
| Davol Inc. | 2 | $164 |
| Heron Therapeutics, Inc. | 3 | $163 |
| Smith+Nephew | 5 | $146 |
| Pacira Pharmaceuticals Incorporated | 3 | $70 |
| Innovation Technologies Inc | 1 | $49 |
| Fidia Pharma USA Inc. | 2 | $36 |
| Medtronic | 1 | $28 |
| Pacira Therapeutics, Inc. | 1 | $22 |
| Heraeus Medical, LLC. | 1 | $18 |
| Abbott | 1 | $16 |
| Theragen, Inc. | 1 | $15 |
| Bioventus LLC | 1 | $13 |
| KCI USA, Inc. | 1 | $13 |
| ERMI LLC | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,308 in reported general payments places this provider in the 55th percentile of 473 orthopaedic surgery providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 41 | $1,651 |
| Diclofenac Sodium | 176 | $1,605 |
| Methylprednisolone | 83 | $603 |
| Cephalexin | 60 | $287 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 23 | $70 |
| Tramadol Hcl | 16 | $28 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Arlington
- Blake PetersonArlington$382K
- Daniel GerscovichArlington$156K
- Dale YoungNorth Chesterfield$10.9M
- James DowdVirginia Beach$6.1M
- Mark de BloisNorth Chesterfield$4M
- Cato LaurencinCharlottesville$3.5M
- Randall PeytonSterling$2.9M
- William MihalkoCharlottesville$2M
- David MillerNorth Chesterfield$1.7M
- Keith LawhornFairfax$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.